{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": 347
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss of PINK1 function is thought to cause early-onset Parkinson disease, and PINK1 is involved in the recruitment of Parkin to damaged mitochondria to promote their autophagic degradation.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving PINK1 and its role in mitochondrial quality control."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The general class of assay used here involves examining the ability of PINK1 variants to recruit Parkin to depolarized mitochondria.",
          "judgment": "Yes",
          "reasoning": "This type of assay effectively models the disease pathogenesis by assessing the core function of PINK1 in mitochondrial quality control.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: The paper includes wild-type PINK1 as a normal control and multiple independent experiments.\n\nStep 3c: Variant Controls: Known pathogenic variants (e.g., L347P) and known benign variants (e.g., G411S) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls were used, and experiments were performed in multiple replicates.\n\nStep 3c: Variant Controls: Variant controls were used, including known pathogenic and benign variants."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: The study used multiple pathogenic and benign variant controls.",
          "judgment": "Yes",
          "reasoning": "Step 4b: No OddsPath Calculation: The paper did not provide OddsPath calculations but used a sufficient number of variant controls."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The L347P variant failed to reconstitute YFP-Parkin recruitment to depolarized mitochondria, consistent with its instability. This functional evidence supports the classification as pathogenic."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": 168
        },
        "variant_string_id": "PINK1 A168P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss of PINK1 function is thought to cause early-onset Parkinson disease, and PINK1 is involved in the recruitment of Parkin to damaged mitochondria to promote their autophagic degradation.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving PINK1 and its role in mitochondrial quality control."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The general class of assay used here involves examining the ability of PINK1 variants to recruit Parkin to depolarized mitochondria.",
          "judgment": "Yes",
          "reasoning": "This type of assay effectively models the disease pathogenesis by assessing the core function of PINK1 in mitochondrial quality control.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: The paper includes wild-type PINK1 as a normal control and multiple independent experiments.\n\nStep 3c: Variant Controls: Known pathogenic variants (e.g., A168P) and known benign variants (e.g., G411S) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls were used, and experiments were performed in multiple replicates.\n\nStep 3c: Variant Controls: Variant controls were used, including known pathogenic and benign variants."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: The study used multiple pathogenic and benign variant controls.",
          "judgment": "Yes",
          "reasoning": "Step 4b: No OddsPath Calculation: The paper did not provide OddsPath calculations but used a sufficient number of variant controls."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The A168P variant failed to reconstitute YFP-Parkin recruitment to depolarized mitochondria, consistent with its pathogenic nature."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "H",
          "alt": "Q",
          "position": 271
        },
        "variant_string_id": "PINK1 H271Q"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss of PINK1 function is thought to cause early-onset Parkinson disease, and PINK1 is involved in the recruitment of Parkin to damaged mitochondria to promote their autophagic degradation.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving PINK1 and its role in mitochondrial quality control."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The general class of assay used here involves examining the ability of PINK1 variants to recruit Parkin to depolarized mitochondria.",
          "judgment": "Yes",
          "reasoning": "This type of assay effectively models the disease pathogenesis by assessing the core function of PINK1 in mitochondrial quality control.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: The paper includes wild-type PINK1 as a normal control and multiple independent experiments.\n\nStep 3c: Variant Controls: Known pathogenic variants (e.g., H271Q) and known benign variants (e.g., G411S) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls were used, and experiments were performed in multiple replicates.\n\nStep 3c: Variant Controls: Variant controls were used, including known pathogenic and benign variants."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: The study used multiple pathogenic and benign variant controls.",
          "judgment": "Yes",
          "reasoning": "Step 4b: No OddsPath Calculation: The paper did not provide OddsPath calculations but used a sufficient number of variant controls."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The H271Q variant failed to reconstitute YFP-Parkin recruitment to depolarized mitochondria, consistent with its pathogenic nature."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": 309
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss of PINK1 function is thought to cause early-onset Parkinson disease, and PINK1 is involved in the recruitment of Parkin to damaged mitochondria to promote their autophagic degradation.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving PINK1 and its role in mitochondrial quality control."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The general class of assay used here involves examining the ability of PINK1 variants to recruit Parkin to depolarized mitochondria.",
          "judgment": "Yes",
          "reasoning": "This type of assay effectively models the disease pathogenesis by assessing the core function of PINK1 in mitochondrial quality control.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: The paper includes wild-type PINK1 as a normal control and multiple independent experiments.\n\nStep 3c: Variant Controls: Known pathogenic variants (e.g., G309D) and known benign variants (e.g., G411S) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls were used, and experiments were performed in multiple replicates.\n\nStep 3c: Variant Controls: Variant controls were used, including known pathogenic and benign variants."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: The study used multiple pathogenic and benign variant controls.",
          "judgment": "Yes",
          "reasoning": "Step 4b: No OddsPath Calculation: The paper did not provide OddsPath calculations but used a sufficient number of variant controls."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The G309D variant only partially reconstituted YFP-Parkin recruitment to depolarized mitochondria, consistent with its partial pathogenic nature."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": 411
        },
        "variant_string_id": "PINK1 G411S"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss of PINK1 function is thought to cause early-onset Parkinson disease, and PINK1 is involved in the recruitment of Parkin to damaged mitochondria to promote their autophagic degradation.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving PINK1 and its role in mitochondrial quality control."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The general class of assay used here involves examining the ability of PINK1 variants to recruit Parkin to depolarized mitochondria.",
          "judgment": "Yes",
          "reasoning": "This type of assay effectively models the disease pathogenesis by assessing the core function of PINK1 in mitochondrial quality control.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Step 3a: Basic Controls and Replicates: The paper includes wild-type PINK1 as a normal control and multiple independent experiments.\n\nStep 3c: Variant Controls: Known pathogenic variants (e.g., L347P) and known benign variants (e.g., G411S) were used as controls.",
          "judgment": "Yes",
          "reasoning": "Step 3a: Basic Controls and Replicates: Both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls were used, and experiments were performed in multiple replicates.\n\nStep 3c: Variant Controls: Variant controls were used, including known pathogenic and benign variants."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Step 4b: No OddsPath Calculation: The study used multiple pathogenic and benign variant controls.",
          "judgment": "Yes",
          "reasoning": "Step 4b: No OddsPath Calculation: The paper did not provide OddsPath calculations but used a sufficient number of variant controls."
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_moderate"
      },
      "overall_conclusion": "The G411S variant reconstituted YFP-Parkin recruitment to depolarized mitochondria to a similar extent as wild-type PINK1, suggesting it is a benign variant."
    }
  ]
}